Figure 6From: Antitumour activity of a potent MEK inhibitor RDEA119/BAY 869766 combined with rapamycin in human orthotopic primary pancreatic cancer xenografts Immunoblotting quantification. Western blot signals were quantified and intensity of phosphorylated and total protein normalized loading control GAPDH was presented (n = 9 for each group). Error bars are SEM. *P < 0.05; **P < 0.01; ***P < 0.001.Back to article page